Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose methylprednisolone before total hip arthroplasty
2015-000102-19Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of methylprednisolone sodium succinate in hip osteoarthritis, sponsored by Rigshospitalet. Primary endpoint: Change in systolic arterial blood pressure. Started May 2015; status: completed.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2015-000102-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000102-19.